LifeSci Acquisition II Corp. (LSAQ) to Combine with Science 37 in $1Bn Deal

LifeSci II (NASDAQ:LSAQ) has entered into a definitive agreement to combine with software firm Science 37 at an enterprise value of $1.05 billion, or 5.8x its 2023E revenue. Los Angeles-based Science 37 provides a software platform that helps organize and accelerate clinical trials by biotech researchers and pharmaceutical companies. The combined entity is expected to
Read More